Urinary metabolomic analysis to identify preterm neonates exposed to histological chorioamnionitis: A pilot study
Open Access
- 6 December 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (12) , e0189120
Abstract
Chorioamnionitis is a leading cause of preterm birth worldwide, with higher incidence at lower gestational ages. An early and reliable diagnosis of histological chorioamnionitis (HCA) in preterm infants may be helpful in guiding postnatal management, especially the administration of prophylactic antibiotics to prevent early-onset sepsis. The main aim of this study was to investigate metabolomic analysis of urines collected in the first 24 hours of life as diagnostic tool of HCA. Gestational age-, birth weight-, delivery mode- and sex- matched (1:2) preterm neonates (< 35 weeks’ gestation) born to mothers with or without HCA were enrolled from an observational study. Gas chromatography-mass spectrometry (GC-MS)-based metabolomic analysis was performed on urine samples non-invasively collected in the first 24 hours of life. Univariate analysis, partial least square discriminant analysis (PLS-DA) and its associated variable importance in projection (VIP) score were performed. The most affected metabolic pathways were examined by Metabolite Sets Enrichment Analysis (MSEA). Fifteen cases (mean GA 30.2 ± 3.8 weeks, mean BW 1415 ± 471.9 grams) and 30 controls (mean GA 30.2 ± 2.9 weeks, mean BW 1426 ± 569.8 grams) were enrolled. Following univariate analysis, 29 metabolites had a significantly different concentration between cases and controls. The supervised PLS-DA model confirmed a separation between the two groups. Only gluconic acid, an oxidation product of glucose, was higher in cases than in controls. All other VIP metabolites were more abundant in the control group. Glutamate metabolism, mitochondrial electron transport chain, citric acid cycle, galactose metabolism, and fructose and mannose degradation metabolism were the most significantly altered pathways (P < 0.01). For the first time, urinary metabolomics was able to discriminate neonates born to mothers with and without HCA. The identification of specifically altered metabolic pathways may be helpful in understanding metabolic derangement following chorioamnionitis.Keywords
Funding Information
- Sardinia Regional Government (PhD scholarship - P.O.R. Sardegna F.S.E. Operational Programme of the Autonomous Region of Sardinia, European Social Fund 2007–2013—Axis IV Human Resources, Objective l.3, Line of Activity l.3.1.)
This publication has 43 references indexed in Scilit:
- Amniotic Fluid: The Use of High-Dimensional Biology to Understand Fetal Well-BeingReproductive Sciences, 2014
- Metabolite Profiling to Characterize Disease-related BacteriaJournal of Biological Chemistry, 2013
- HMDB 3.0—The Human Metabolome Database in 2013Nucleic Acids Research, 2012
- A Clinical Prediction Rule for Histological Chorioamnionitis in Preterm NewbornsPLOS ONE, 2012
- Prolonged Initial Empirical Antibiotic Treatment is Associated with Adverse Outcomes in Premature InfantsThe Journal of Pediatrics, 2011
- Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalystNature Protocols, 2011
- Diagnosis and Management of Clinical ChorioamnionitisClinics in Perinatology, 2010
- How Bacteria Consume Their Own Exoskeletons (Turnover and Recycling of Cell Wall Peptidoglycan)Microbiology and Molecular Biology Reviews, 2008
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort StudyGut, 2007